Related Experiment Video

Updated: Aug 4, 2026

In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model
07:05

In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model

Published on: November 28, 2017

Genetically modified tumour vaccines (GMTV) in melanoma clinical trials

S Nawrocki1, P Murawa, J Malicki

  • 1Department of Radiation Oncology, Great Poland Cancer Centre, ul. Garbary 15, 61-866, Poznań, Poland.

Immunology Letters
|September 21, 2000
PubMed

Insights

A novel melanoma vaccine modified with IL-6 and sIL-6R genes shows promise in treating metastatic melanoma. Preclinical and early clinical trials indicate effective anti-tumor responses and improved survival, leading to a phase III trial.

Area of Science:

  • Oncology
  • Immunology
  • Vaccine Development

Background:

  • Melanoma is an immunogenic malignancy often incurable in its disseminated phase.
  • Various immunotherapeutic approaches, including genetically modified tumor vaccines (GMTV), are under investigation.

Purpose of the Study:

  • To develop and evaluate a novel, mixed auto/allogeneic cellular melanoma vaccine genetically modified with IL-6 and soluble IL-6 receptor (sIL-6R) genes.

Main Methods:

  • Preclinical studies in a mouse model.
  • Development of a cellular melanoma vaccine incorporating IL-6 and sIL-6R genes.
  • Clinical trials involving vaccination of metastatic melanoma patients.

Main Results:

  • Preclinical studies demonstrated effective anti-tumor responses mediated by CD8+ and NK cells, inhibiting tumor growth, metastasis, and prolonging survival.
  • Irradiation of vaccine cells enhanced IL-6 and sIL-6R secretion.
  • Over 100 metastatic melanoma patients were vaccinated, showing promising clinical results (22% CR+PR, 32% SD) and evidence of immune responses.

Conclusions:

  • The IL-6/sIL-6R based melanoma vaccine elicits significant anti-tumor activity and immune responses.
  • The vaccine demonstrates potential for treating metastatic melanoma, warranting further investigation in larger trials.

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...